Advertisement

Baxter confirms rumors by announcing that it signed a definitive agreement to acquire Swedish dialysis devices maker Gambro AB for a total of about $4 billion.

mergers and acquisitions illustration

Rumors circulating late last month proved true with Baxter (NYSE:BAX) this week announced that it had signed a $4 billion (26.5 billion SEK) merger agreement with Swedish dialysis Gambro.

The deal, to be paid through a combination of cash and deb, gives Baxter a strong foothold in the dialysis devices arena and complements the company's existing home dialysis product portfolio, the company noted.

Advertisement
Advertisement